tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SE:MVIR Stock Latest News

Medivir names nomination committee ahead of 2026 AGM
Company AnnouncementsMedivir names nomination committee ahead of 2026 AGM
4d ago
Medivir to Highlight Key Liver Cancer Study at Redeye Fight Cancer Event 2026
PremiumCompany Announcements
Medivir to Highlight Key Liver Cancer Study at Redeye Fight Cancer Event 2026
13d ago
Medivir Reshapes Board Leadership at Extraordinary General Meeting
PremiumCompany Announcements
Medivir Reshapes Board Leadership at Extraordinary General Meeting
18d ago
Medivir Boosts Share Capital and Expands Share Base After Rights Issue
PremiumCompany Announcements
Medivir Boosts Share Capital and Expands Share Base After Rights Issue
1M ago
Medivir Calls Extraordinary General Meeting with Expanded Voting Options
PremiumCompany Announcements
Medivir Calls Extraordinary General Meeting with Expanded Voting Options
1M ago
Medivir AB Announces CFO Departure Amid Ongoing Cancer Treatment Developments
PremiumCompany AnnouncementsMedivir AB Announces CFO Departure Amid Ongoing Cancer Treatment Developments
2M ago
Medivir AB Secures SEK 151 Million Through Rights Issue
Premium
Company Announcements
Medivir AB Secures SEK 151 Million Through Rights Issue
2M ago
Medivir to Present Promising Liver Cancer Study at Redeye Life Science Day
Premium
Company Announcements
Medivir to Present Promising Liver Cancer Study at Redeye Life Science Day
2M ago
Medivir’s Partner Vetbiolix Publishes Landmark Study on Canine Periodontitis Treatment
PremiumCompany Announcements
Medivir’s Partner Vetbiolix Publishes Landmark Study on Canine Periodontitis Treatment
2M ago
Medivir’s MIV-711 Receives FDA Orphan Drug Designation for Osteogenesis Imperfecta
PremiumCompany Announcements
Medivir’s MIV-711 Receives FDA Orphan Drug Designation for Osteogenesis Imperfecta
2M ago
Medivir to Present at Aktiespararnas Stora Aktiedagar on New Cancer Treatment Study
PremiumCompany Announcements
Medivir to Present at Aktiespararnas Stora Aktiedagar on New Cancer Treatment Study
2M ago
Medivir AB to Present at DNB Carnegie Nordic Healthcare Conference
PremiumCompany Announcements
Medivir AB to Present at DNB Carnegie Nordic Healthcare Conference
2M ago
Medivir AB Announces Live Business Update and New Cancer Study
PremiumCompany AnnouncementsMedivir AB Announces Live Business Update and New Cancer Study
3M ago
Medivir Announces New Share Issue to Strengthen Financial Position
Premium
Company Announcements
Medivir Announces New Share Issue to Strengthen Financial Position
3M ago
Medivir AB Adopts Key Resolutions at Extraordinary General Meeting
Premium
Company Announcements
Medivir AB Adopts Key Resolutions at Extraordinary General Meeting
3M ago
Medivir AB Strengthens IP and Advances Cancer Drug Development
PremiumCompany Announcements
Medivir AB Strengthens IP and Advances Cancer Drug Development
3M ago
Medivir Postpones Nomination Committee Appointment Amid Rights Issue
PremiumCompany Announcements
Medivir Postpones Nomination Committee Appointment Amid Rights Issue
3M ago
Medivir Licenses Remetinostat to Biossil for Global Development
PremiumCompany Announcements
Medivir Licenses Remetinostat to Biossil for Global Development
3M ago
Medivir AB Announces Extraordinary General Meeting for Shareholders
PremiumCompany Announcements
Medivir AB Announces Extraordinary General Meeting for Shareholders
4M ago
Medivir Announces Fully Guaranteed Rights Issue to Fund Clinical Study
PremiumCompany AnnouncementsMedivir Announces Fully Guaranteed Rights Issue to Fund Clinical Study
4M ago
Medivir AB Reports Progress in Liver Cancer Treatment Development
Premium
Company Announcements
Medivir AB Reports Progress in Liver Cancer Treatment Development
5M ago
Medivir Secures Japanese Patent for Liver Cancer Treatment
Premium
Company Announcements
Medivir Secures Japanese Patent for Liver Cancer Treatment
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >